Sabine Druillennec

2.1k citations
25 papers · 1.3k indexed · h-index 17
Topics
HIV Research and Treatment (12 papers)Melanoma and MAPK Pathways (6 papers)HIV/AIDS drug development and treatment (6 papers)
Partner nations
FranceAustriaCanada

In The Last Decade

Sabine Druillennec

25 papers receiving 1.3k citations

Peers

Sabine Druillennec
Comparison fields: 5 of 81
  • Molecular Biology 731
  • Virology 602
  • Infectious Diseases 369
  • Immunology 282
  • Epidemiology 215
Replace Carlos M. C. de Noronha with:
Carlos M. C. de Noronha United States
Guochun Jiang United States
Elias G. Argyris United States
Andrew H. Kaplan United States
Ling‐Jun Zhao United States
Emmanuel Ségéral France
Larisa Dubrovsky United States
Uriel Hazan France
José Carlos Valle‐Casuso France
Tatiana Pushkarsky United States
Sabine Druillennec relative to Carlos M. C. de Noronha United States Carlos M. C. de Noronha's profile →
Citations per field
00.5×1.6×
Carlos M. C. de Noronha · 1×
Citations per year

Countries citing papers authored by Sabine Druillennec

Since Specialization
Citations

This map shows the geographic impact of Sabine Druillennec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Druillennec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Druillennec more than expected).

Fields of papers citing papers by Sabine Druillennec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sabine Druillennec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Druillennec. The network helps show where Sabine Druillennec may publish in the future.

Co-authorship network of co-authors of Sabine Druillennec

This figure shows the co-authorship network connecting the top 25 collaborators of Sabine Druillennec. A scholar is included among the top collaborators of Sabine Druillennec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sabine Druillennec. Sabine Druillennec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 11
2 15
3 35
4 21
5 11
6 65
7 36
8 28
9 2
10 31
11 75
12 43
13 23
14 71
15
HIV-1 NCp7 as a target for the design of novel antiviral agents.
9
16 51
17 390
18
HIV‐1ヌクレオカプシド蛋白質模倣体は逆転写を阻害し,抗ウイルス活性を示す
19
19 10
20 75

About Sabine Druillennec

Sabine Druillennec is a scholar working on Virology, Immunology and Allergy and Infectious Diseases, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (12 papers), Melanoma and MAPK Pathways (6 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Virology (602 citations), Infectious Diseases (369 citations) and Immunology (282 citations). Sabine Druillennec has collaborated with scholars based in France, Austria and Canada. Frequent co-authors include Bernárd P. Roques, Guido Kroemer, Alain Eychène, Helena L.A. Vieira, John C. Reed, Markus Loeffler, Johan Hoebeke, Karine F. Ferri, Naoufal Zamzami and Étienne Jacotot. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026